公开(公告)号：US20220202743A1

公开(公告)日：2022-06-30

申请号：US17610879

申请日：2020-05-13

Applicant: VASTHERA CO. LTD.

Inventor： Ho Jeong KWON ,  Hui-Yun HWANG

IPC: A61K31/135 ,  A61P25/16 ,  A61P25/28 ,  A23L33/10

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating a degenerative brain disease, and a pharmaceutical composition may be provided for preventing or treating a degenerative brain disease, which comprises one or more selected from the group consisting of a compound represented by the following Chemical Formula 1 and a pharmaceutically acceptable salt thereof as an active ingredient.

公开(公告)号：US20220265579A1

公开(公告)日：2022-08-25

申请号：US17610958

申请日：2020-05-13

Applicant: VASTHERA CO. LTD.

Inventor： Ho Jeong KWON ,  Hui-Yun HWANG

IPC: A61K31/135 ,  A23L33/10 ,  A61P9/10 ,  A61K9/00

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating a cardio-cerebrovascular disease, and a pharmaceutical composition may be provided for preventing or treating a cardio-cerebrovascular disease, which comprises one or more selected from the group consisting of a compound represented by the following Chemical Formula 1 and a pharmaceutically acceptable salt thereof as an active ingredient.